Man Group plc - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 68 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 3.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
Man Group plc ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$376,000
-73.8%
28,983
-73.8%
0.00%
-83.3%
Q1 2021$1,435,000
-66.9%
110,555
-64.7%
0.01%
-68.4%
Q4 2020$4,331,000
-8.5%
313,183
-2.5%
0.02%0.0%
Q3 2020$4,732,000
-7.7%
321,253
+1.9%
0.02%
-26.9%
Q2 2020$5,124,000
+322.4%
315,331
+277.2%
0.03%
+225.0%
Q1 2020$1,213,000
+748.3%
83,588
+299.9%
0.01%
+700.0%
Q4 2018$143,000
-62.7%
20,900
-63.8%
0.00%0.0%
Q3 2018$383,000
+16.4%
57,700
-1.4%
0.00%0.0%
Q2 2018$329,000
+93.5%
58,500
+78.4%
0.00%0.0%
Q1 2018$170,00032,8000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders